General MedicationsORALStandard
SODIUM IODIDE I 131
SODIUM IODIDE I-131
Standard Dose
0.009-0.1mCi
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 021305 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM IODIDE I-131 Form and strength CAPSULE;ORAL - 0.009-0.1mCi Sponsor JUBILANT Submission history Latest submission status date: 2021-06-11 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM IODIDE I 131 is listed in Drugs@FDA under application 021305 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM IODIDE I-131 Form and strength CAPSULE;ORAL - 0.009-0.1mCi Sponsor JUBILANT Submission history Latest submission status date: 2021-06-11 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.